S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
Profit From the Commercial Solar Boom? (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
What do Mastercard Earnings Indicate About Consumer Spending?
Profit From the Commercial Solar Boom? (Ad)
How to Find Penny Stocks to Invest and Trade
ONSemi Is Marching Higher On Great Results
Profit From the Commercial Solar Boom? (Ad)
What Tyson Foods Q1 Means For Staples Stocks
Can Cummins Power To A New High? 
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
Profit From the Commercial Solar Boom? (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
What do Mastercard Earnings Indicate About Consumer Spending?
Profit From the Commercial Solar Boom? (Ad)
How to Find Penny Stocks to Invest and Trade
ONSemi Is Marching Higher On Great Results
Profit From the Commercial Solar Boom? (Ad)
What Tyson Foods Q1 Means For Staples Stocks
Can Cummins Power To A New High? 
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
Profit From the Commercial Solar Boom? (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
What do Mastercard Earnings Indicate About Consumer Spending?
Profit From the Commercial Solar Boom? (Ad)
How to Find Penny Stocks to Invest and Trade
ONSemi Is Marching Higher On Great Results
Profit From the Commercial Solar Boom? (Ad)
What Tyson Foods Q1 Means For Staples Stocks
Can Cummins Power To A New High? 
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
Profit From the Commercial Solar Boom? (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
What do Mastercard Earnings Indicate About Consumer Spending?
Profit From the Commercial Solar Boom? (Ad)
How to Find Penny Stocks to Invest and Trade
ONSemi Is Marching Higher On Great Results
Profit From the Commercial Solar Boom? (Ad)
What Tyson Foods Q1 Means For Staples Stocks
Can Cummins Power To A New High? 
NASDAQ:CFMS

Conformis - CFMS Stock Forecast, Price & News

$2.47
-0.15 (-5.73%)
(As of 02/6/2023 12:00 AM ET)
Add
Compare
Today's Range
$2.46
$2.71
50-Day Range
$2.46
$3.78
52-Week Range
$1.20
$18.77
Volume
43,406 shs
Average Volume
38,967 shs
Market Capitalization
$18.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.50

Conformis MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
82.2% Upside
$4.50 Price Target
Short Interest
Healthy
0.99% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($8.32) to ($5.43) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.16 out of 5 stars

Medical Sector

321st out of 1,027 stocks

Surgical Appliances & Supplies Industry

10th out of 23 stocks

CFMS stock logo

About Conformis (NASDAQ:CFMS) Stock

ConforMIS, Inc. is a medical technology company, which engages in the development, manufacture, and sale of joint replacement implants. It operates through the following geographical segments: United States, Germany, and Rest of the World. The firm's products include iUni, iDuo, iTotal CR, and iTotal. The company was founded by Philipp Lang in 2004 and is headquartered in Billerica, MA.

Receive CFMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Conformis and its competitors with MarketBeat's FREE daily newsletter.

CFMS Stock News Headlines

Profit From the Commercial Solar Boom?
Solar energy had its best year ever in 2021, with a record 24 gigawatts of power installed. That's enough to power 18 million homes! Analysts expect the global solar farm market to reach $356 billion by 2028. The utility segment of the solar market is expected to grow at the highest annual growth rate in the industry, especially with the many tax incentives now offered.
Conformis Announces Full Commercial Launch of Imprint™
The #1 Energy Stock to Buy
The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…
Conformis, Inc. Effects 1-for-25 Reverse Stock Split
Conformis Reports Third Quarter 2022 Financial Results
Conformis, Inc. (CFMS)
Here's Why ConforMIS (CFMS) Stock is Tanking Today
See More Headlines
Receive CFMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Conformis and its competitors with MarketBeat's FREE daily newsletter.

CFMS Company Calendar

Last Earnings
11/03/2021
Today
2/06/2023
Next Earnings (Confirmed)
3/01/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CFMS
Employees
310
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$4.50
High Stock Price Forecast
$8.00
Low Stock Price Forecast
$1.00
Forecasted Upside/Downside
+82.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-2,410,000.00
Net Margins
-104.46%
Pretax Margin
-104.45%

Debt

Sales & Book Value

Annual Sales
$99.86 million
Cash Flow
$0.24 per share
Book Value
$13.51 per share

Miscellaneous

Free Float
7,239,000
Market Cap
$18.57 million
Optionable
Not Optionable
Beta
1.03

Key Executives

  • Mark A. AugustiMark A. Augusti
    President, Chief Executive Officer & Director
  • Michael Fillion
    Chief Operating Officer
  • Robert S. HoweRobert S. Howe
    CFO, Treasurer & Principal Accounting Officer
  • John Slamin
    Chief Technology Officer
  • Marc Quartulli
    Vice President-Clinical Affairs & Market Access













CFMS Stock - Frequently Asked Questions

Should I buy or sell Conformis stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Conformis in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CFMS shares.
View CFMS analyst ratings
or view top-rated stocks.

What is Conformis' stock price forecast for 2023?

2 brokers have issued 1 year price targets for Conformis' stock. Their CFMS share price forecasts range from $1.00 to $8.00. On average, they predict the company's share price to reach $4.50 in the next year. This suggests a possible upside of 82.2% from the stock's current price.
View analysts price targets for CFMS
or view top-rated stocks among Wall Street analysts.

How have CFMS shares performed in 2023?

Conformis' stock was trading at $3.32 at the beginning of the year. Since then, CFMS stock has decreased by 25.6% and is now trading at $2.47.
View the best growth stocks for 2023 here
.

When is Conformis' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 1st 2023.
View our CFMS earnings forecast
.

How can I listen to Conformis' earnings call?

Conformis will be holding an earnings conference call on Wednesday, March 1st at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Conformis' earnings last quarter?

Conformis, Inc. (NASDAQ:CFMS) released its quarterly earnings data on Wednesday, November, 3rd. The medical instruments supplier reported ($0.07) EPS for the quarter, hitting the consensus estimate of ($0.07). The medical instruments supplier earned $14.25 million during the quarter, compared to the consensus estimate of $14.08 million. Conformis had a negative trailing twelve-month return on equity of 78.14% and a negative net margin of 104.46%. During the same quarter in the prior year, the firm earned ($0.09) earnings per share.

What guidance has Conformis issued on next quarter's earnings?

Conformis updated its fourth quarter 2022 earnings guidance on Wednesday, November, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $13.00 million-$14.00 million, compared to the consensus revenue estimate of $15.99 million.

What is Mark Augusti's approval rating as Conformis' CEO?

15 employees have rated Conformis Chief Executive Officer Mark Augusti on Glassdoor.com. Mark Augusti has an approval rating of 55% among the company's employees. This puts Mark Augusti in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Conformis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Conformis investors own include Advanced Micro Devices (AMD), Martin Midstream Partners (MMLP), Micron Technology (MU), NVIDIA (NVDA), Trevena (TRVN), Cisco Systems (CSCO), Pfizer (PFE), AbbVie (ABBV), Alibaba Group (BABA) and AT&T (T).

When did Conformis IPO?

(CFMS) raised $135 million in an initial public offering on Wednesday, July 1st 2015. The company issued 9,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

What is Conformis' stock symbol?

Conformis trades on the NASDAQ under the ticker symbol "CFMS."

Who are Conformis' major shareholders?

Conformis' stock is owned by a number of institutional and retail investors. Top institutional investors include Avidian Wealth Solutions LLC (0.49%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include J Brent Alldredge, Kenneth P Fallon III, Mark A Augusti, Mark A Augusti and Robert S Howe.
View institutional ownership trends
.

How do I buy shares of Conformis?

Shares of CFMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Conformis' stock price today?

One share of CFMS stock can currently be purchased for approximately $2.47.

How much money does Conformis make?

Conformis (NASDAQ:CFMS) has a market capitalization of $18.57 million and generates $99.86 million in revenue each year. The medical instruments supplier earns $-2,410,000.00 in net income (profit) each year or ($8.75) on an earnings per share basis.

How many employees does Conformis have?

The company employs 310 workers across the globe.

How can I contact Conformis?

Conformis' mailing address is 600 TECHNOLOGY PARK DRIVE, BILLERICA MA, 01821. The official website for the company is www.conformis.com. The medical instruments supplier can be reached via phone at (781) 345-9001, via email at ir@conformis.com, or via fax at 781-345-0147.

This page (NASDAQ:CFMS) was last updated on 2/7/2023 by MarketBeat.com Staff